News Archives | Future Medicine India


Abbott researchers identify a new HIV-1 subtype

The global health care company, Abbott, has announced that they identified a new subtype of the human immunodeficiency virus, called HIV-1 Group M, subtype L.

FM News Network
Read More..

Antigen-based screening test for early detection of breast cancer on way

Breast cancer could be diagnosed up to five years before there are any clinical symptoms with the new blood test identifying tumour-associated antigens (TAAs), shows a recent study.

FM News Network

Measles infection could cause wipe out body’s immune memory in unvaccinated

Measles infection may lead to depletion of certain specific B and T memory cells of the immune system, resetting the immunity, finds a recent Harvard research.

FM News Network

NIH to launch MDR-TB prevention trial in India

National Institutes of Health (NIH) has announced to launch a Phase III multidrug-resistant TB (MDR-TB) prevention clinical trial-Phoenix- in 12 high tuberculosis burden countries including India.

IIIT researchers develop novel predictive model to identify melanoma progression

Scientists from Indraprastha Institute of Information Technology (IIIT), New Delhi have developed a method to distinguish primary and metastatic cutaneous melanoma using the expression of six novel putative markers for the disease.

FM News Network

Unitaid joins hands with Stellenbosch University to develop child-friendly therapy for multidrug-resistant tuberculosis

Stellenbosch University and Unitaid have signed an m.o.u for US$ 18.9 million grant to develop child-friendly and preventive therapy for treating multidrug-resistant TB in children.

FM News Network

TB drug rifampentine prices slashed by two-thirds

The Unitaid, Global Fund and Sanofi has jointly announced a new agreement to reduce the price of a critically important tuberculosis drug- rifapentine by 66 percent.

FM News Network